Clinical Scorecard: Transitioning to CAIRS
At a Glance
| Category | Detail |
|---|---|
| Condition | Keratoconus |
| Key Mechanisms | CAIRS is a tissue-based alternative to synthetic intracorneal ring segments. |
| Target Population | Corneal and refractive surgeons interested in treating keratoconus with CAIRS. |
| Care Setting | AAO instruction course on adopting CAIRS. |
Key Highlights
- CAIRS was developed in 2015 by Soosan Jacob as a biological alternative to synthetic intracorneal ring segments.
- The AAO 2026 course addressed how surgeons can begin performing CAIRS and select initial cases.
- Course topics included femtosecond-dissected and manually created channels.
- Instruction covered segment cutting with femtosecond techniques or double-bladed trephines, as well as customization and nomograms.
- The course also discussed tissue sources and operating-room organization.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with keratoconus considered for CAIRS; the article does not specify eligibility criteria.
CAIRS is described as an increasingly popular tissue-based option, but not yet a universal first-line treatment for keratoconus.
Clinical Best Practices
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.